Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors

Journal of Vascular Surgery

Volumn 29, Issue 3, 1999, Pages 543-550

  Schneider, D B ^a   Sassani, A B ^a   Vassalli, G ^a   Driscoll, R M ^a   Dichek, D A ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL TISSUE; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; GENE EXPRESSION REGULATION; GENE TARGETING; HISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0032996496     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(99)70283-1     Document Type: Article

References (40)

1. EG Nabel Gene therapy for cardiovascular disease Circulation 91 1995 541 548
2. DA Dichek Interventional approaches to the introduction of genetic material into the cardiovascular system 3rd ed EJ Topol Textbook of interventional cardiology 1999 WB Saunders Philadelphia 703 724
3. T Ohno D Gordon H San VJ Pompili MJ Imperiale GJ Nabel Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science 265 1994 781 784
4. MW Chang E Barr J Seltzer Y-Q Jiang GJ Nabel EG Nabel Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science 267 1995 518 522
5. JJ Rade AH Schulick R Virmani DA Dichek Local adenoviral-mediated expression of recombinant hirudin reduces neointimal formation after arterial injury Nat Med 2 1996 293 298
6. P Zoldhelyi J McNatt X-M Xu D Loose-Mitchell RS Meidell FJ Clubb Jr Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene Circulation 93 1996 10 17
7. KIP1, an inhibitor of neointima formation in the rat carotid artery J Clin Invest 99 1997 2334 2341
8. U Hedin E Wahlberg Gene therapy and vascular disease: Potential applications in vascular surgery Eur J Vasc Endovasc Surg 13 1997 101 111
9. KD Newman PF Dunn JW Owens AH Schulick R Virmani G Sukhova Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia J Clin Invest 96 1995 2955 2965
10. A Lafont G Loirand P Pacaud F Vilde P Lemarchand D Escande Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector Hum Gene Ther 8 1997 1033 1040
11. AH Schulick G Vassalli PF Dunn G Dong JJ Rade C Zamarron Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity J Clin Invest 99 1997 209 219
12. IJ Kullo G Mozes RS Schwartz P Gloviczki TB Crotty DA Barber Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity Circulation 96 1997 2254 2261
13. H Ooboshi MJ Welsh CD Rios BL Davidson DD Heistad Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue Circ Res 77 1995 7 13
14. CD Ríos H Ooboshi D Piegors BL Davidson DD Heistad Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach Arterioscler Thromb Vasc Biol 15 1995 2241 2245
15. M Laitinen T Pakkanen E Donetti R Baetta J Luoma P Lehtolainen Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses Hum Gene Ther 8 1997 1645 1650
16. G Dong AH Schulick MB DeYoung DA Dichek Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-β1 responsiveness in endothelium in vivo J Biol Chem 271 1996 29969 29977
17. S-M Kang DB Schneider Z Lin D Hanahan DA Dichek PG Stock Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction Nat Med 3 1997 738 743
18. SW Lee BC Trapnell JJ Rade R Virmani DA Dichek In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries Circ Res 73 1993 797 807
19. N Mittereder KL March BC Trapnell Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 70 1996 7498 7509
20. AH Schulick KD Newman R Virmani DA Dichek In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity Circulation 91 1995 2407 2414
21. BJ Roessler ED Allen JM Wilson JW Hartman BL Davidson Adenoviral-mediated gene transfer to rabbit synovium in vivo J Clin Invest 92 1993 1085 1092
22. G-P Gao Y Yang JM Wilson Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy J Virol 70 1996 8934 8943
23. FW Van Ginkel C Liu JW Simecka J-Y Dong T Greenway RA Frizzell Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase Hum Gene Ther 6 1995 895 903
24. JH Zar Biostatistical analysis 1984 Prentice-Hall Englewood Cliffs (NJ)
25. JJ Rome V Shayani MY Flugelman KD Newman A Farb R Virmani Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector Arterioscl Thromb 14 1994 148 161
26. T Tsukada D Tippens D Gordon R Ross AM Gown HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization Am J Pathol 126 1987 51 60
27. AF Drew PG Tipping T helper cell infiltration and foam cell proliferation are early events in the development of atherosclerosis in cholesterol-fed rabbits Arterioscler Thromb Vasc Biol 15 1995 1563 1568
28. T Tsukada M Rosenfeld R Ross AM Gown Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit Arteriosclerosis 6 1986 601 613
29. DB Schneider CA Fly DA Dichek RL Geary Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates Hum Gene Ther 9 1998 815 821
30. S Glagov E Weisenberg CK Zarins R Stankunavicius GJ Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371 1375
31. Y Shi M Pieniek A Fard J O'Brien JD Mannion A Zalewski Adventitial remodeling after coronary arterial injury Circulation 93 1996 340 348
32. Y Shi JE O'Brien Jr A Fard JD Mannion D Wang A Zalewski Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries Circulation 94 1996 1655 1664
33. NA Scott GD Cipolla CE Ross B Dunn FH Martin L Simonet Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries Circulation 93 1996 2178 2187
34. H Sawa C Lundgren BE Sobel S Fujii Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: A potential progenitor of restenosis J Am Coll Cardiol 24 1994 1742 1748
35. Y Shi JE O'Brien Jr A Fard A Zalewski Transforming growth factor-β1 expression and myofibroblast formation during arterial repair Arterioscl Thromb Vasc Biol 16 1996 1298 1305
36. JD Marmur M Rossikhina A Guha B Fyfe V Friedrich M Mendlowitz Tissue factor is rapidly induced in arterial smooth muscle after balloon injury J Clin Invest 91 1993 2253 2259
37. M Simons ER Edelman J-L DeKeyser R Langer RD Rosenberg Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Nature 359 1992 67 70
38. Y Zhang WJ Cliff GI Schoefl G Higgins Immunohistochemical study of intimal microvessels in coronary atherosclerosis Am J Pathol 143 1993 164 172
39. R Virmani A Farb A Burke Atlas of Cardiovascular Pathology 1996 WB Saunders Philadelphia
40. P Flomenberg V Piaskowski RL Truitt JT Casper Characterization of human proliferative T cell responses to adenovirus J Infect Dis 171 1995 1090 1096